Angiocrine Bioscience

United States

series-b

Stage

About

Angiocrine Bioscience is a clinical stage biotechnology company developing innovative cell therapies for hematologic diseases and cancer by targeting endothelial cells that regulate blood and lymphatic vessels.

Explore Angiocrine Bioscience's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.